Table 3.
Most frequently occurring drugs in patient reports assessed in VigiBase during the signal-detection workshop
| Drug | No. of drug–event combinations |
|---|---|
| Levothyroxine | 22 |
| Desogestrel | 17 |
| Nitrofurantoin | 8 |
| Noscapine | 5 |
| Human papilloma vaccine | 4 |
| Metronidazole | 4 |
| Herbal NOS | 3 |
| Proguanil hydrochloride/Atovaquone | 3 |
| Xylometazoline hydrochloride/ipratropium bromide | 3 |
| Dequalinium | 3 |
| Clarithromycin | 3 |
| Colecalciferol | 3 |
| Estradiol valerate/dienogest | 3 |
| Liothyronine | 3 |
| Insulin lispro/Insulin lispro protamine suspension | 2 |
| Ethinylestradiol/etonogestrel | 2 |
| Exemestane | 2 |
| Finasteride | 2 |
| Gadobutrol | 2 |
NOS not otherwise specified